A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant loss of -75.13% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 33.33%. Over the past 30 days, the price of PACB has fallen by 49.69%. And in the last five days, it has surged by 37.85%.
The market performance of Pacific Biosciences of California Inc has been somewhat unstable. Over the past year, the company’s stock achieved a high of $10.65 on 12/27/23, with the lowest value for the same timeframe being $1.16, recorded on 07/02/24.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
52-week price history of PACB Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Pacific Biosciences of California Inc’s current trading price is -77.09% away from its 52-week high, while its distance from the 52-week low is 110.34%. The stock’s price range for this period has been between $1.16 and $10.65. The Healthcare sector company’s shares saw a trading volume of about 10.38 million for the day, which was higher than the average daily volume of 8.11 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Pacific Biosciences of California Inc (PACB) has experienced a quarterly rise of 57.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 747.71M and boasts a workforce of 796 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.69, with a change in price of +0.62. Similarly, Pacific Biosciences of California Inc recorded 8,730,519 in trading volume during the last 100 days, posting a change of +34.07%.
PACB’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PACB stands at 1.88. Similarly, the long-term debt-to-equity ratio is also 1.85.
PACB Stock Stochastic Average
As of today, the raw stochastic average of Pacific Biosciences of California Inc over the last 50 days is at 95.51%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 94.91%. Further, the company’s Stochastic %K and %D values for the last 20 days were 82.40% and 78.37%, respectively.
